Cargando…
Antiviral Abidol is Associated with the Reduction of In-Hospital Mortality in COVID-19 Patients
OBJECTIVE: Coronavirus disease 2019 (COVID-19) is a global public health crisis. There are no specific antiviral agents for the treatment of SARS-CoV-2. Information regarding the effect of Abidol on in-hospital mortality is scarce. The present study aimed to evaluate the treatment effect of Abidol f...
Autores principales: | Zeng, Hesong, He, Xingwei, Liu, Wanjun, Kan, Jing, He, Liqun, Zhao, Jinhe, Chen, Cynthia, Zhang, Junjie, Chen, Shaoliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710295/ https://www.ncbi.nlm.nih.gov/pubmed/34977907 http://dx.doi.org/10.1097/CD9.0000000000000014 |
Ejemplares similares
-
A New Coronavirus Estimation Global Score for Predicting Mortality During Hospitalization in Patients with COVID-19
por: Zeng, Hesong, et al.
Publicado: (2022) -
Establishment of a meta-analysis based novel aortic dissection mouse model
por: Jiang, Hongcheng, et al.
Publicado: (2022) -
One-stop interventional procedure for bicuspid aortic stenosis in a patient with coexisting aortic coarctation: a case report
por: He, Xingwei, et al.
Publicado: (2023) -
A nomogram for predicting echocardiogram prescription in outpatients: an analysis of the NAMCS database
por: Liu, Yujian, et al.
Publicado: (2023) -
The Value of Cardiopulmonary Exercise Testing in Predicting the Severity of Coronary Artery Disease
por: Liu, Wanjun, et al.
Publicado: (2022)